Coloplast A/S

kr 508.20As of Sun 8 Nov 2026, 12:00 UTC
CPH:COLO-BHealthcare
Country Denmark
PE (Fwd) •••
TSR 10Y CAGR 3.40%
Div yield 4.53%
ROE 20.21%
Medical Instruments & Supplies
Beta (5Y) 0.57
PE TTM 37.26
TSR TTM (9.33%)
Mkt cap kr 114.4B
ROIC 16.60%
SE Grade™
Value
Quality
Moat
Consensus
Reference
kr 615
20.96%
(94.13%)
Hold 2|9|1|12|1
1Q26
2Q26
3Q26
4Q26
Earnings per sharekr
6.89
7.12
7.84
8.42
(0.61%)
(4.33%)
7.24%
17.89%
Revenuekr B
11.33
11.12
11.15
11.16
12.18%
3.93%
6.18%
3.13%
Peers (US$17.06B)
Cap (US$)
PE
11.86B
49.36x
3.409B
35.62x
2.684B
—
15.79B
61.10x
Capital
TTM
5Y
10Y
Leveragex
0.292
(0.054)
(0.049)
EBIT/Intx
0.877
0.179
0.209
Own earn%
144.93
42.01
27.29
Sh yield%
32.57
54.25
53.99
Owners
Insiders/Inst%
6.70
49.68
Short interest%
3.33
SBC / revenue%
4.66
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
7
Op margin range%
3–8
$1 testx
—
Incr. ROIC%
11